295 related articles for article (PubMed ID: 18071313)
1. Distinct genomic aberration patterns are found in familial breast cancer associated with different immunohistochemical subtypes.
Melchor L; Honrado E; García MJ; Alvarez S; Palacios J; Osorio A; Nathanson KL; Benítez J
Oncogene; 2008 May; 27(22):3165-75. PubMed ID: 18071313
[TBL] [Abstract][Full Text] [Related]
2. An integrative hypothesis about the origin and development of sporadic and familial breast cancer subtypes.
Melchor L; Benítez J
Carcinogenesis; 2008 Aug; 29(8):1475-82. PubMed ID: 18596026
[TBL] [Abstract][Full Text] [Related]
3. Distinct patterns of DNA copy number alteration are associated with different clinicopathological features and gene-expression subtypes of breast cancer.
Bergamaschi A; Kim YH; Wang P; Sørlie T; Hernandez-Boussard T; Lonning PE; Tibshirani R; Børresen-Dale AL; Pollack JR
Genes Chromosomes Cancer; 2006 Nov; 45(11):1033-40. PubMed ID: 16897746
[TBL] [Abstract][Full Text] [Related]
4. Distinct genomic profiles in hereditary breast tumors identified by array-based comparative genomic hybridization.
Jönsson G; Naylor TL; Vallon-Christersson J; Staaf J; Huang J; Ward MR; Greshock JD; Luts L; Olsson H; Rahman N; Stratton M; Ringnér M; Borg A; Weber BL
Cancer Res; 2005 Sep; 65(17):7612-21. PubMed ID: 16140926
[TBL] [Abstract][Full Text] [Related]
5. High-resolution genomic profiles of breast cancer cell lines assessed by tiling BAC array comparative genomic hybridization.
Jönsson G; Staaf J; Olsson E; Heidenblad M; Vallon-Christersson J; Osoegawa K; de Jong P; Oredsson S; Ringnér M; Höglund M; Borg A
Genes Chromosomes Cancer; 2007 Jun; 46(6):543-58. PubMed ID: 17334996
[TBL] [Abstract][Full Text] [Related]
6. The accumulation of specific amplifications characterizes two different genomic pathways of evolution of familial breast tumors.
Melchor L; Alvarez S; Honrado E; Palacios J; Barroso A; Díez O; Osorio A; Benítez J
Clin Cancer Res; 2005 Dec; 11(24 Pt 1):8577-84. PubMed ID: 16361540
[TBL] [Abstract][Full Text] [Related]
7. Identification of cell-of-origin breast tumor subtypes in inflammatory breast cancer by gene expression profiling.
Van Laere SJ; Van den Eynden GG; Van der Auwera I; Vandenberghe M; van Dam P; Van Marck EA; van Golen KL; Vermeulen PB; Dirix LY
Breast Cancer Res Treat; 2006 Feb; 95(3):243-55. PubMed ID: 16261404
[TBL] [Abstract][Full Text] [Related]
8. Estrogen receptor status could modulate the genomic pattern in familial and sporadic breast cancer.
Melchor L; Honrado E; Huang J; Alvarez S; Naylor TL; García MJ; Osorio A; Blesa D; Stratton MR; Weber BL; Cigudosa JC; Rahman N; Nathanson KL; Benítez J
Clin Cancer Res; 2007 Dec; 13(24):7305-13. PubMed ID: 18094411
[TBL] [Abstract][Full Text] [Related]
9. Comparative genomic hybridization profiles in human BRCA1 and BRCA2 breast tumors highlight differential sets of genomic aberrations.
van Beers EH; van Welsem T; Wessels LF; Li Y; Oldenburg RA; Devilee P; Cornelisse CJ; Verhoef S; Hogervorst FB; van't Veer LJ; Nederlof PM
Cancer Res; 2005 Feb; 65(3):822-7. PubMed ID: 15705879
[TBL] [Abstract][Full Text] [Related]
10. Familial breast cancers without mutations in BRCA1 or BRCA2 have low cyclin E and high cyclin D1 in contrast to cancers in BRCA mutation carriers.
Aaltonen K; Blomqvist C; Amini RM; Eerola H; Aittomäki K; Heikkilä P; Nevanlinna H
Clin Cancer Res; 2008 Apr; 14(7):1976-83. PubMed ID: 18381935
[TBL] [Abstract][Full Text] [Related]
11. Phenotypic characterization of BRCA1 and BRCA2 tumors based in a tissue microarray study with 37 immunohistochemical markers.
Palacios J; Honrado E; Osorio A; Cazorla A; Sarrió D; Barroso A; Rodríguez S; Cigudosa JC; Diez O; Alonso C; Lerma E; Dopazo J; Rivas C; Benítez J
Breast Cancer Res Treat; 2005 Mar; 90(1):5-14. PubMed ID: 15770521
[TBL] [Abstract][Full Text] [Related]
12. Characterization of familial non-BRCA1/2 breast tumors by loss of heterozygosity and immunophenotyping.
Oldenburg RA; Kroeze-Jansema K; Meijers-Heijboer H; van Asperen CJ; Hoogerbrugge N; van Leeuwen I; Vasen HF; Cleton-Jansen AM; Kraan J; Houwing-Duistermaat JJ; Morreau H; Cornelisse CJ; Devilee P
Clin Cancer Res; 2006 Mar; 12(6):1693-700. PubMed ID: 16551851
[TBL] [Abstract][Full Text] [Related]
13. Integrated profiling of basal and luminal breast cancers.
Adélaïde J; Finetti P; Bekhouche I; Repellini L; Geneix J; Sircoulomb F; Charafe-Jauffret E; Cervera N; Desplans J; Parzy D; Schoenmakers E; Viens P; Jacquemier J; Birnbaum D; Bertucci F; Chaffanet M
Cancer Res; 2007 Dec; 67(24):11565-75. PubMed ID: 18089785
[TBL] [Abstract][Full Text] [Related]
14. Caveolin-1 expression is associated with a basal-like phenotype in sporadic and hereditary breast cancer.
Pinilla SM; Honrado E; Hardisson D; Benítez J; Palacios J
Breast Cancer Res Treat; 2006 Sep; 99(1):85-90. PubMed ID: 16541313
[TBL] [Abstract][Full Text] [Related]
15. Molecular characterization of breast cancer with high-resolution oligonucleotide comparative genomic hybridization array.
Andre F; Job B; Dessen P; Tordai A; Michiels S; Liedtke C; Richon C; Yan K; Wang B; Vassal G; Delaloge S; Hortobagyi GN; Symmans WF; Lazar V; Pusztai L
Clin Cancer Res; 2009 Jan; 15(2):441-51. PubMed ID: 19147748
[TBL] [Abstract][Full Text] [Related]
16. Subtypes of familial breast tumours revealed by expression and copy number profiling.
Waddell N; Arnold J; Cocciardi S; da Silva L; Marsh A; Riley J; Johnstone CN; Orloff M; Assie G; Eng C; Reid L; Keith P; Yan M; Fox S; Devilee P; Godwin AK; Hogervorst FB; Couch F; ; Grimmond S; Flanagan JM; Khanna K; Simpson PT; Lakhani SR; Chenevix-Trench G
Breast Cancer Res Treat; 2010 Oct; 123(3):661-77. PubMed ID: 19960244
[TBL] [Abstract][Full Text] [Related]
17. MYB oncogene amplification in hereditary BRCA1 breast cancer.
Kauraniemi P; Hedenfalk I; Persson K; Duggan DJ; Tanner M; Johannsson O; Olsson H; Trent JM; Isola J; Borg A
Cancer Res; 2000 Oct; 60(19):5323-8. PubMed ID: 11034064
[TBL] [Abstract][Full Text] [Related]
18. Use of expression data and the CGEMS genome-wide breast cancer association study to identify genes that may modify risk in BRCA1/2 mutation carriers.
Walker LC; Waddell N; Ten Haaf A; ; Grimmond S; Spurdle AB
Breast Cancer Res Treat; 2008 Nov; 112(2):229-36. PubMed ID: 18095154
[TBL] [Abstract][Full Text] [Related]
19. Comparative genomic hybridization analysis of breast tumors with predetermined profiles of DNA amplification.
Courjal F; Theillet C
Cancer Res; 1997 Oct; 57(19):4368-77. PubMed ID: 9331100
[TBL] [Abstract][Full Text] [Related]
20. Genomic signature of BRCA1 deficiency in sporadic basal-like breast tumors.
Joosse SA; Brandwijk KI; Mulder L; Wesseling J; Hannemann J; Nederlof PM
Genes Chromosomes Cancer; 2011 Feb; 50(2):71-81. PubMed ID: 21104783
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
